Pricing Log in Create free account

Ernexa Therapeutics Inc. (ERNA) vs Onconetix, Inc. (ONCO)

Ernexa Therapeutics Inc. and Onconetix, Inc. are both Biotechnology companies. Ernexa Therapeutics Inc. and Onconetix, Inc. are of similar size ($3.2M and $3.0M). Onconetix, Inc. grew revenue faster over the last twelve months: −51.3% against −78.6%. Ernexa Therapeutics Inc. has the higher net margin (0.00% vs −1,578.6%) and the higher return on invested capital (0.00% vs −135.4%). Across the 16 metrics below, Ernexa Therapeutics Inc. leads on 9 and Onconetix, Inc. on 7.

Valuation

Metric ERNA ONCO Biotechnology median
P/E n/m n/m 10.60
P/S 3.82 23.65 9.40
P/B 0.70 1.13 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 50.76 14.63 9.02
Earnings yield (992.55%) (2,931.13%) (32.88%)
Free cash flow yield (399.18%) (67.68%) (23.13%)

Profitability

Metric ERNA ONCO Biotechnology median
Gross margin 83.51% 80.38% 68.51%
Operating margin 0.00% (2,524.73%) 0.00%
Net margin 0.00% (1,578.60%) 0.00%
Free cash flow margin 0.00% (1,595.90%) 0.00%
Return on equity (321.22%) (105.23%) (51.96%)
Return on assets (176.62%) (57.37%) (46.06%)
Return on invested capital 0.00% (135.42%) 0.00%

Growth

Metric ERNA ONCO Biotechnology median
Revenue growth (TTM) (78.60%) (51.33%) 6.76%
EPS growth (last fiscal year) 95.42% 99.09% 29.88%
Revenue growth, 5-year CAGR (52.20%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ERNA ONCO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.01 2.21 4.97
Net debt to EBITDA 0.21 0.29 1.01

Dividend

Metric ERNA ONCO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ERNA ONCO Biotechnology median
Market cap 2.99m 3.24m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack